ArticleJournal of gastroenterology and hepatology2022

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis.

Makoto Naganuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.